Rankings
▼
Calendar
HROW Q2 2016 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$5M
Gross Profit
$3M
55.7% margin
Operating Income
-$4M
-81.7% margin
Net Income
-$5M
-94.5% margin
EPS (Diluted)
$-0.35
QoQ Revenue Growth
+12.0%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$6M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$22M
Total Liabilities
$16M
Stockholders' Equity
$6M
Cash & Equivalents
$5M
← FY 2016
All Quarters
Q3 2016 →
